Pierre Sujobert

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon et al. · British Journal of Dermatology · 2021 · 387 citations · Full text

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways

Jérôme Tamburini, Nicolas Chapuis, Valérie Bardet et al. · Blood · 2007 · 252 citations

Essential role for the p110  isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia

Pierre Sujobert · Blood · 2005 · 244 citations · Full text

The Genetic Basis of Hepatosplenic T-cell Lymphoma

Matthew McKinney, Andrea B. Moffitt, Philippe Gaulard et al. · Cancer Discovery · 2017 · 195 citations · Full text

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

Laury Poulain, Pierre Sujobert, Florence Zylbersztejn et al. · Leukemia · 2017 · 140 citations

Hematological Malignancy, Molecular Pharmacology, G6pd Inhibition +9